We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 51

Bayer v. Canada
  • Gowling Lafleur Henderson LLP
  • Canada
  • May 28 2009

The Court of Appeal dismissed Bayer’s appeal, thus affirming the refusal to list the patent on the Patent Register


Apotex v. Canada (Minister of Health)
  • Gowling Lafleur Henderson LLP
  • Canada
  • May 28 2009

Apotex brought a judicial review of the Minister’s refusal to issue a NOC regarding its version of aspirin


Lundbeck v. Ratiopharm and Cobalt
  • Gowling Lafleur Henderson LLP
  • Canada
  • May 28 2009

The Court of Appeal upheld the decision of the applications judge who struck the applications for judicial review


Eli Lilly v. Canada (Minister of Health)
  • Gowling Lafleur Henderson LLP
  • Canada
  • May 28 2009

Eli Lilly had submitted patent lists seeking to add the newly issued patent at issue to the Patent Register with respect to several supplemental new drug submissions


Novopharm Limited v. Eli Lilly Canada Inc
  • Gowling Lafleur Henderson LLP
  • Canada
  • May 28 2009

The Court of Appeal dismissed the appeal of the generic company from a decision of the motions judge refusing to dismiss the proceeding as a whole


Federal Court of Appeal upholds denial of innovator profits and refuses to grant damages for future lost market share in first case under s. 8 of the PM(NOC) Regulations
  • Gowling Lafleur Henderson LLP
  • Canada
  • June 5 2009

In September 2008, the Federal Court released its first decision interpreting s. 8 of the PM(NOC) Regulations


Pfizer v. Novopharm
  • Gowling Lafleur Henderson LLP
  • Canada
  • June 24 2009

The Federal Court granted prohibition in respect of a patent claiming the use of sildenafil for the treatment of erectile dysfunction by oral administration


Celgene v. Canada
  • Gowling Lafleur Henderson LLP
  • Canada
  • June 24 2009

Celgene is the current owner of several patents relating to thalidomide


Aventis v. Pharmascience; motion to set aside a previous order of prohibition; 2009 FC 915; ramipril; September 15, 2009
  • Gowling Lafleur Henderson LLP
  • Canada
  • September 30 2009

Pharmascience had previously sent an Notice of Allegation (NOA) with respect to a patent to Aventis, resulting in a full hearing and appeal, concluding with an order of prohibition


Pfizer v. Apotex
  • Gowling Lafleur Henderson LLP
  • Canada
  • April 7 2009

The Court upheld the decision of the Prothonotary refusing further production of ANDS documents